مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

205
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

104
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

APLASTIC ANEMIA EVOLVING TO MYELODYSPLASTIC SYNDROME AND LATER TO A LYMPHOPROLIFERATIVE MALIGNANCY IN A TREATED CASE OF CARCINOMA BREAST: A CASE REPORT EMPHASIZING THE IMPORTANCE OF PET-CT IN CUTANEOUS T CELL LYMPHOMA

Pages

  66-69

Abstract

 Although APLASTIC ANEMIA (AA) and MYELODYSPLASTIC SYNDROME (MDS) are separate entities with different management, distinction between the two can be difficult on morphological basis due to hypocellularity of bone marrow. MDS is one of the serious complications of AA. Karyotyping is definitive in the diagnosis of MDS. Better and robust investigations like18F-Fluoro-deoxy-Glucose Positron Emission Tomography/Computed Tomography (18F-FDG PET-CT) are essential in high risk patients with haematological malignancies and in those relapsing within a short period of time after initiation of therapy or having refractory disease. It might be helpful in the development of individual treatment algorithms for these high-risk patients. There may be unique problems in hematological malignancies where the transformation of one pathology into another may be silent with no biomarkers that can predict this transformation e.g. transformation of MDS from AA. Studies have shown that immune suppression can lead to a variety of haematological and lymphoproliferative disorders which may co-exist.18F-FDG PET-CT may be useful in identifying the primary or occult sites of malignancy and also can direct the site from which biopsy can be attempted. We present a patient with Carcinoma right breast who developed hematological and lymphoproliferative disorders during the course of her treatment. In this case, AA transformed to MDS with abnormal karyotype (chromosome 9 mutation) and then progressed further to manifest CUTANEOUS T CELL LYMPHOMA before patient succumbed to her illness. Immune mediated suppression of haemopoiesis has been considered the most important mechanism in this case.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    PADMA, SUBRAMANYAM, & SUNDARAM, PALANISWAMY SHANMUGA. (2017). APLASTIC ANEMIA EVOLVING TO MYELODYSPLASTIC SYNDROME AND LATER TO A LYMPHOPROLIFERATIVE MALIGNANCY IN A TREATED CASE OF CARCINOMA BREAST: A CASE REPORT EMPHASIZING THE IMPORTANCE OF PET-CT IN CUTANEOUS T CELL LYMPHOMA. IRANIAN JOURNAL OF NUCLEAR MEDICINE, 25(1 (SERIAL NUMBER 47)), 66-69. SID. https://sid.ir/paper/728302/en

    Vancouver: Copy

    PADMA SUBRAMANYAM, SUNDARAM PALANISWAMY SHANMUGA. APLASTIC ANEMIA EVOLVING TO MYELODYSPLASTIC SYNDROME AND LATER TO A LYMPHOPROLIFERATIVE MALIGNANCY IN A TREATED CASE OF CARCINOMA BREAST: A CASE REPORT EMPHASIZING THE IMPORTANCE OF PET-CT IN CUTANEOUS T CELL LYMPHOMA. IRANIAN JOURNAL OF NUCLEAR MEDICINE[Internet]. 2017;25(1 (SERIAL NUMBER 47)):66-69. Available from: https://sid.ir/paper/728302/en

    IEEE: Copy

    SUBRAMANYAM PADMA, and PALANISWAMY SHANMUGA SUNDARAM, “APLASTIC ANEMIA EVOLVING TO MYELODYSPLASTIC SYNDROME AND LATER TO A LYMPHOPROLIFERATIVE MALIGNANCY IN A TREATED CASE OF CARCINOMA BREAST: A CASE REPORT EMPHASIZING THE IMPORTANCE OF PET-CT IN CUTANEOUS T CELL LYMPHOMA,” IRANIAN JOURNAL OF NUCLEAR MEDICINE, vol. 25, no. 1 (SERIAL NUMBER 47), pp. 66–69, 2017, [Online]. Available: https://sid.ir/paper/728302/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button